High initial APACHE II scores in neurosurgery ICU patients were significantly associated with early clinical deterioration, supporting its use for proactive monitoring.
Does the APACHE II score predict early clinical deterioration in a neurosurgery ICU cohort?
The APACHE II score demonstrates good prognostic accuracy for early clinical deterioration in neurosurgery ICU patients, supporting its use as a proactive trigger for enhanced monitoring.
Absolute Event Rate: 0% vs 0%
This study provides empirical validation of APACHE II in this neurosurgery cohort, demonstrating good prognostic accuracy. The significant association established between high initial scores and early clinical deterioration suggests its potential utility as an objective trigger for enhanced monitoring. These findings support a shift toward using the score proactively, although validation in larger multi-center cohorts is required.
Fauzan et al. (Tue,) reported a other. High initial APACHE II scores in neurosurgery ICU patients were significantly associated with early clinical deterioration, supporting its use for proactive monitoring.